The underwriting results beat analyst expectations across the board, aided by a benign Q2 for cats and the benefit of compounding rate increases from prior periods now starting to meaningfully earn through.
It
The underwriting results beat analyst expectations across the board, aided by a benign Q2 for cats and the benefit of compounding rate increases from prior periods now starting to meaningfully earn through.
It